Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Protopic adverse event reports that FDA received

Name type
Product name as reported

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Drug reports received through . Device reports have a separate cutoff, 30 Sep 2026. Why a report count is not a rate.

Reports on file

From January 2004 to June 2026, FDA received 1,901 adverse event reports that name Protopic. The name is as reporters wrote it. In these reports the drug is a suspect or interacting product.

In the same period, 2,172 further reports name it only as a concomitant medicine. The counts on this page do not include these reports.

FDA received 54 reports in the 12 months to June 2026 and 103 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 54 (under 0.1%) name Protopic. Reports for patients aged 18 to 44 were 23.1% of the reports that name Protopic and 12.3% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.

There are many instances of duplicative reports and some reports do not contain all the necessary information.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Suspect product

FDA records each drug in a report as suspect, concomitant or interacting. This page counts the reports in which Protopic is suspect or interacting. FDA says:

Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Since the last update

FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

The latest update of the FDA data, recorded on , changed no count of this page.

  • In April to June 2026, FDA received 13 reports that name Protopic.
  • In January to March 2026, FDA received 21.
  • In April to June 2025, FDA received 22.

April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.

All updatesFeed of updates (RSS)

Reaction lookup

These are the reaction terms that the reports record, with the number of reports for each term. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 210 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for all 1,901 reports.

The site keeps a term for a year only if two or more reports of that year record it.

So a count in the table can be lower than the count of FDA.

The table shows the first 50 of 210 terms.

Reaction terms in the reports that name Protopic, most reports first
Reaction term (MedDRA) and plain meaningReportsShare of the 1,901 reports
Off label useused for a purpose or in a way not on the label32817.3%
Pruritusitching1749.2%
Drug ineffectivethe medicine did not work as expected1578.3%
Product use in unapproved indicationused for a purpose not on the label1256.6%
Erythemaskin redness1156%
Skin exfoliationpeeling skin1045.5%
Skin burning sensationburning skin834.4%
Dermatitis atopic824.3%
Insomniadifficulty sleeping814.3%
Product use issuea problem in how the product was used784.1%
Rashskin rash764%
Burning sensationa burning feeling743.9%
Condition aggravatedthe condition being treated got worse663.5%
Application site pain653.4%
Skin weeping643.4%
Lymphadenopathyswollen lymph nodes613.2%
Gastroenteritisstomach bug603.2%
Cataractclouding of the eye lens573%
Painpain, site not specified562.9%
Topical steroid withdrawal reaction562.9%
Fatiguetiredness542.8%
Dyspepsiaindigestion532.8%
Dysphagiadifficulty swallowing532.8%
Eczema492.6%
Steroid withdrawal syndrome482.5%
Skin atrophy422.2%
Pyrexiafever392.1%
Hypersensitivityan allergic-type reaction382%
Drug ineffective for unapproved indication361.9%
Alopeciahair loss351.8%
Psoriasispsoriasis, a skin condition341.8%
Skin papilloma341.8%
Dry skin321.7%
Medication errora mistake in prescribing, dispensing or taking a medicine291.5%
Neuralgia291.5%
Application site pruritusitching where the product was applied281.5%
Treatment failurethe treatment did not work271.4%
Dyspnoeashortness of breath261.4%
Pain of skin261.4%
Anxiety251.3%
Application site erythemaredness where the product was applied241.3%
Pain in extremitypain in an arm or leg241.3%
Squamous cell carcinoma241.3%
Skin infection231.2%
Eye irritation221.2%
Peripheral swellingswelling of the arms or legs221.2%
Feeling abnormalfeeling odd or not right211.1%
Inappropriate schedule of product administrationthe product was taken at the wrong times211.1%
Skin disorder211.1%
Cellulitisa skin infection201.1%

Download all 210 terms of Protopic (CSV)

The counts add to more than 1,901 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The CSV file has the same rows and the same limits. Its last row is a note that says so.

MedDRA term

The person who codes a report selects the preferred term that agrees best with the description of the reporter. The words under a term are the plain meaning that this site gives.

Not the label

The FDA-approved label of a product lists its adverse reactions. See the official pages at the end of this page.

Outcomes by year

The table gives the outcomes that the reporters gave, in the terms of FDA.

Outcomes in the reports that name Protopic, by the year of the openFDA file that holds the report

The table continues to the right.

Year of the openFDA fileReportsSeriousDeathLife-threateningHospitalization (initial or prolonged)Disability or Permanent DamageCongenital Anomaly/Birth DefectOther Serious (Important Medical Events)Not serious
20042019151120101
200564623141382402
200695871132873588
200754442510122810
200869568717213713
200969594623304110
20106160342140381
2011353353631232
20124843141630305
2013187563182147131
2014187763474068111
20151565203112047104
201658300511502528
201790480022302642
201886600413414426
201963440314503019
20207566129210509
202198921415320756
202255450061203810
202386420171203944
2024126951221108531
2025787111323191637
20264138011110353

An outcome in a report is not proof that the drug was the cause. The reporter gives the outcome, and FDA does not verify it. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The six headings with the names of FDA are the outcome terms of FDA. A report can have more than one outcome. The columns Serious and Not serious are the two values of the openFDA field serious. For the value serious, openFDA gives this description:

The adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition

Source: openFDA, Drug adverse event fields (YAML reference). The site read the page on .

The year is the year of the openFDA file that holds the latest version of the report. It is not always the year in which FDA first received the report. The chart of the next section uses the year of first receipt. The latest year is not complete.

Reports by year and month

Reports that name Protopic, by the year in which FDA received them
0100200200420082012201620202024

The column of 2026 has an outline, because the year is not complete. It has the reports that FDA received through June 2026 only.

Show the figures of the chart as a table
Reports that name Protopic, by the year in which FDA received them
YearReports
200419
200564
200690
200752
200867
200970
201068
201138
201252
2013196
2014179
2015152
201659
201796
201895
201968
202074
2021100
202247
202386
2024118
202575
202634
Reports that name Protopic, by month, five years to June 2026
0255020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Why a count moves

A count moves for many reasons. The guide gives FDA's words about them.

Patients and reporters

Age of the patient in the reports that name Protopic
AgeReportsShareShare as a bar
Under 2382%
2 to 111578.3%
12 to 17804.2%
18 to 4443923.1%
45 to 6426113.7%
65 to 741135.9%
75 and over653.4%
Age not given74839.3%
Sex of the patient in the reports that name Protopic
SexReportsShareShare as a bar
Female1,06255.9%
Male70036.8%
Unknown or not given1397.3%
Type of reporter in the reports that name Protopic
ReporterReportsShareShare as a bar
Physician51527.1%
Pharmacist884.6%
Other health professional27614.5%
Lawyer301.6%
Consumer or non-health professional93849.3%
Not given542.8%

Age and sex are as the report gives them. The reporter is the primary source in the report. 44.5% of the reports give the United States as the country.

Reason for use

Reason for use (indication) that the reports of Protopic record
Indication as recorded (MedDRA)ReportsShare
Dermatitis atopic35618.7%
Eczema31116.4%
Vitiligo1156%
Psoriasis673.5%
Lichen planus231.2%
Dermatitis191%

The reporter fills in the indication, and the field is often empty. Each share is of all 1,901 reports.

Drugs in the same reports

Other drugs that the reports of Protopic name, in any role, in order of name
DrugReports that name the two
Advair Hfa46
Aspirin43
Clobetasol108
Eumovate50
Hydrocortisone87
Methotrexate62
Prednisolone76
Prednisone120
Pulmicort Turbuhaler55
Theophylline54

The table has the 10 drug names that these reports name most. Two names in one report says only that the report recorded the two. It says nothing about the part of a product in the event.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Pages near this one

These links are for navigation. No count selected them.

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Protopic: adverse event reports that FDA received. https://reportedreactions.com/drug/protopic/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

A report is in the count when it names Protopic as a suspect or interacting product. The 2,172 reports that name it only as a concomitant medicine are not in the count. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Do these reports show that Protopic was responsible for the reactions?

No. FDA says:

For any given report, there is no certainty that a suspected drug caused the event.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

A reaction can relate to the condition that the drug treats, to other medicines, or to something else.

Is this the list of reactions on the label of Protopic?

No. It is a count of what people reported to FDA: 1,901 reports from January 2004 to June 2026. The FDA-approved label of a product lists its adverse reactions. The official pages at the end of this page link to the labels.

Who sent these reports?

Consumer or non-health professional (49.3%), physician (27.1%) and other health professional (14.5%). These are the types of reporter for the reports that name this drug.

If a manufacturer receives an adverse event report, it is normally required to send the report to FDA.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.